Poland, March 20 -- Poland based Janssen Cilag Polska Sp. z o.o. has secured contract from Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie for Pharmaceutical products Delivery of medicinal products containing the active substances Talquetamab and Daratumumab. The value of the contract is worth 1429578815 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....